VALEANT PHARMACEUTICALS INTERNATIONAL Contracts & Agreements

VALEANT PHARMACEUTICALS INTERNATIONAL (Filed With SEC on October 1, 2010)

FIRST SUPPLEMENTAL INDENTURE (Filed With SEC on October 1, 2010)

CREDIT AND GUARANTY AGREEMENT (Filed With SEC on October 1, 2010)

AGREEMENT AND PLAN OF MERGER Dated as of June 20, 2010, Among Valeant Pharmaceuticals International, Biovail Corporation, Biovail Americas Corp. and Beach Merger Corp. (Filed With SEC on June 23, 2010)

GOLDMAN SACHS BANK USA GOLDMAN SACHS LENDING PARTNERS LLC 200 West Street New York, New York 10282 MORGAN STANLEY SENIOR FUNDING, INC. 1585 Broadway New York, New York 10036... (Filed With SEC on June 23, 2010)

BIOVAIL CORPORATION (Filed With SEC on June 23, 2010)

BIOVAIL CORPORATION NON-EXECUTIVE CHAIRMAN AND BIOVAIL LABORATORIES INTERNATIONAL SRL PRESIDENT AGREEMENT (Filed With SEC on June 23, 2010)

deliver periodic financial and other information (Filed With SEC on June 2, 2010)

AMENDMENT TO EMPLOYMENT OFFER LETTER (Filed With SEC on April 5, 2010)

VALEANT PHARMACEUTICALS INTERNATIONAL (Filed With SEC on March 29, 2010)

Entry into a Material Definitive Agreement (Filed With SEC on December 21, 2009)

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers (Filed With SEC on December 1, 2009)

Unaudited, in thousands, except par value data (Filed With SEC on November 2, 2009)

Waiver, Release and Option Agreement for Taribavirin (Filed With SEC on August 5, 2009)

AGREEMENT AND PLAN OF MERGER (Filed With SEC on May 22, 2009)

In thousands, except par value data (Filed With SEC on May 7, 2009)

Year Ended December 31 (Filed With SEC on March 2, 2009)

Agreement and Plan of Merger, dated December 9, 2008, by and among Valeant Pharmaceuticals International, Descartes Acquisition Corp., Dow Pharmaceutical Sciences, Inc., and... (Filed With SEC on January 5, 2009)

Financial Statements (Filed With SEC on November 10, 2008)

Nine Months (Filed With SEC on March 17, 2008)

VALEANT PHARMACEUTICALS INTERNATIONAL EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on February 6, 2008)

SEPARATION AGREEMENT (Filed With SEC on February 6, 2008)

RELEASE AGREEMENT (Filed With SEC on February 6, 2008)

Financial Statements (Filed With SEC on August 7, 2007)

Year Ended December 31 (Filed With SEC on March 1, 2007)

Valeant Pharmaceuticals International 2006 Equity Incentive Plan (Filed With SEC on May 25, 2006)

Year Ended December 31 (Filed With SEC on March 16, 2006)

Product Purchase Agreement, dated as of November 28, 2005, by and between Valeant Pharmaceuticals North America and InterMune, Inc (Filed With SEC on January 5, 2006)

VALEANT PHARMACEUTICALS INTERNATIONAL (Filed With SEC on December 30, 2005)

Financial Statements (Filed With SEC on August 9, 2005)

Financial Statements (Filed With SEC on May 10, 2005)

Exhibit No (Filed With SEC on April 27, 2005)

Financial performance of the Company as determined by the Committee. For fiscal year 2005, participants in the EIP are measured on one or more of the following financial... (Filed With SEC on February 28, 2005)

Exhibit Number (Filed With SEC on February 4, 2005)

Certificate of Designation, Preferences and Rights of Series A Participating Preferred Stock of Valeant Pharmaceuticals International, filed with the Secretary of State of the... (Filed With SEC on October 6, 2004)

Legal Proceedings (Filed With SEC on March 15, 2004)

Exhibit Number (Filed With SEC on November 25, 2003)

Legal Proceedings (Filed With SEC on March 27, 2002)

Category

Industry

Companies

Contracts

VALEANT PHARMACEUTICALS INTERNATIONAL Contracts & Agreements